Frontier Wealth Management LLC Unicycive Therapeutics, Inc. Transaction History
Frontier Wealth Management LLC
- $8.02 Billion
- Q2 2022
A detailed history of Frontier Wealth Management LLC transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Frontier Wealth Management LLC holds 18,800 shares of UNCY stock, worth $12,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,800
Previous 18,800
-0.0%
Holding current value
$12,220
Previous $20,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding UNCY
# of Institutions
29Shares Held
60.2MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA11.4MShares$7.39 Million1.76% of portfolio
-
Great Point Partners LLC Greenwich, CT11MShares$7.14 Million5.72% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT10.4MShares$6.75 Million0.41% of portfolio
-
Octagon Capital Advisors LP New York, NY10MShares$6.5 Million1.76% of portfolio
-
Logos Global Management LP San Francisco, CA5.08MShares$3.3 Million0.53% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $9.78M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...